Telefield Medical Imaging Completed the Pre-A Round Financing Totalling Nearly 40 Million HK Dollars to Drive China’s Original Technological Innovations for Medical Imaging

By
Media Outreach
-
0
HONG KONG SAR – Media OutReach – 19 May 2023 – Telefield Medical Imaging (TMI) Limited is the world’s leading provider of AI 3D ultrasound imaging technology, equipment and solutions. It offers a pioneering radiation-free 3D ultrasonic scoliosis assessment system called Scolioscan, which provides novel solutions for safe and efficient scoliosis assessment. The company has gained recognition and support from many well-known investment institutions and completed the Pre-A round of financing, totalling nearly HK$40 million in April 2023. So far, the total financing has exceeded HK$100 million. Investors in this financing round include Fosun Pharma, AEF Greater Bay Area Fund managed by Gobi Partners GBA, The Hong Kong Polytechnic University (PolyU) and some industrial investors. The funds will be used to further accelerate product development and market expansion and attract more outstanding talents to join the team.

https://www.linkedin.com/company/telefield-medical-imaging-limited

The issuer is solely responsible for the content of this announcement.

About Telefield Medical Imaging Limited

Telefield Medical Imaging Limited (TMI) is a leading global provider of 3D ultrasound imaging technology, equipment and solutions, with the headquarters in Hong Kong. Its original AI 3D ultrasound imaging technology platform has 19 global pioneering and leading technologies with more than 100 patents. So far, many of its products have obtained medical equipment certification in the EU, Australia and Mainland China, providing 3D ultrasound imaging solutions applicable to the prevention, assessment and treatment of multiple musculoskeletal disorders. Scolioscan, a brand of products under TMI, is dedicated to becoming the preferred radiation-free medical assessment tool for the prevention and treatment of scientific exercise and musculoskeletal chronic disease. It can be used for scoliosis screening, diagnosis, follow-up monitoring, progression prediction, visual feedback during non-surgical treatment, as well as outcome measurement of treatment. It provides radiation-free scoliosis assessment solutions with an accuracy comparable to X-ray imaging for experts in orthopedics, rehabilitation and sports therapy.